Holdings

Stempoint Capital LP

As of Sep 30, 2026, Stempoint Capital LP reported 71 positions worth US$502M. Largest: Scholar Rock Holding Corporation, Erasca, Inc. and Abivax SA. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Scholar Rock Holding Corporation689KUS$33.3M+450KSep 30, 2026
Erasca, Inc.2.26MUS$33.1M+695KSep 30, 2026
Abivax SA279KUS$27.7M−4,259Sep 30, 2026
Tango Therapeutics, Inc.989KUS$24.7M−234KSep 30, 2026
Roivant Sciences Ltd.641KUS$23.5M+293KSep 30, 2026
First Tracks Biotherapeutics, Inc.650KUS$23M+27,201Sep 30, 2026
Enliven Therapeutics, Inc.330KUS$15.1M−16,438Sep 30, 2026
Adaptive Biotechnologies Corporation464KUS$13.4MnewSep 30, 2026
Dianthus Therapeutics, Inc.151KUS$13.3M−50,075Sep 30, 2026
Sensei Biotherapeutics, Inc.405KUS$12MnewSep 30, 2026